Evidence map›Paper›PMID 29276006›Full record

ArticleAmerican journal of human genetics2018

WNT Signaling Perturbations Underlie the Genetic Heterogeneity of Robinow Syndrome.

Janson J White, Juliana F Mazzeu, Zeynep Coban-Akdemir, Yavuz Bayram, Vahid Bahrambeigi, Alexander Hoischen, Bregje W M van Bon, Alper Gezdirici, Elif Yilmaz Gulec, Francis Ramond and 26 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 111 citations in OpenAlex.

  1. Robinow syndrome DVL1 variants disrupt morphogenesis and appendage formation in a Drosophila disease model.Developmental dynamics : an official publication of the American Association of Anatomists · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. ATranslational pediatrics · 2025
    Article
  12. Article
  13. Article
  14. Molecules That Have Rarely Been Studied in Lymphatic Endothelial Cells.International journal of molecular sciences · 2024
    Review
  15. The origin and evolution of Wnt signalling.Nature reviews. Genetics · 2024
    Review
  16. Article
  17. Article
  18. An unusual presentation of de novo RAC3 variation in prenatal diagnosis.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2024
    Article
  19. Core planar cell polarity genesProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  20. Closing the gap: Solving complex medically relevant genes at scale.medRxiv : the preprint server for health sciences · 2024
    Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 18 institutions in 6 countries.

Janson J WhiteDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston TX 77030, USA.
Juliana F MazzeuUniversity of Brasilia, Brasilia 70910, Brazil; Robinow Syndrome Foundation, Anoka, MN 55303, USA.
Zeynep Coban-AkdemirDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston TX 77030, USA.
Yavuz BayramDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston TX 77030, USA.
Vahid BahrambeigiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston TX 77030, USA; Graduate Program in Diagnostic Genetics, School of Health Professions, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Alexander HoischenDepartment of Human Genetics, Radboud Institute of Molecular Life Sciences, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Bregje W M van BonDepartment of Human Genetics, Radboud Institute of Molecular Life Sciences, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Alper GezdiriciDepartment of Medical Genetics, Kanuni Sultan Suleyman Training and Research Hospital, Istanbul 34303, Turkey.
Elif Yilmaz GulecDepartment of Medical Genetics, Kanuni Sultan Suleyman Training and Research Hospital, Istanbul 34303, Turkey.
Francis RamondService de Génétique, CHU-Hôpital Nord, 42000 Saint-Etienne, France.
Renaud TouraineService de Génétique, CHU-Hôpital Nord, 42000 Saint-Etienne, France.
Julien ThevenonInserm UMR 1231 GAD team, Genetics of Developmental Anomalies, Université de Bourgogne-Franche Comté, 21000 Dijon, France; FHU-TRANSLAD, Université de Bourgogne, 21000 CHU Dijon, France; Centre de génétique, Hôpital Couple-Enfant, CHU de Grenoble-Alpes, 38700 La Tronche, France.
Marwan ShinawiDivision of Genetics and Genomic Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Erin BeaverMercy Clinic-Kids Genetics, Mercy Children's Hospital St. Louis, St. Louis, MO 63141, USA.
Jennifer HeeleyMercy Clinic-Kids Genetics, Mercy Children's Hospital St. Louis, St. Louis, MO 63141, USA.
Julie Hoover-FongGreenberg Center for Skeletal Dysplasias, McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University, Baltimore, MD 21287, USA.
Ceren D DurmazDepartment of Medical Genetics, Ankara University School of Medicine, 06100 Ankara, Turkey.
Halil Gurhan KarabulutDepartment of Medical Genetics, Ankara University School of Medicine, 06100 Ankara, Turkey.
Ebru Marzioglu-OzdemirDepartment of Medical Genetics, Erzurum Regional and Training Hospital, 25070 Erzurum, Turkey.
Atilla CayirErzurum Training and Research Hospital, Department of Pediatric Endocrinology, 25070 Erzurum, Turkey.
Mehmet B DuzDepartment of Medical Genetics, Cerrahpasa Medical School, Istanbul University, 34452 Istanbul, Turkey.
Mehmet SevenDepartment of Medical Genetics, Cerrahpasa Medical School, Istanbul University, 34452 Istanbul, Turkey.
Susan PriceOxford Centre for Genomic Medicine, Nuffield Orthopaedic Centre, Oxford OX3 7LD, UK.
Barbara Merfort FerreiraUniversity of Brasilia, Brasilia 70910, Brazil.
Angela M Vianna-MorganteDepartment of Genetics and Evolutionary Biology, Institute of Biosciences, Sao Paulo - SP 05508-090, Brazil.
Sian EllardDepartment of Molecular Genetics, Royal Devon and Exeter NHS Foundation Trust, Exeter EX2 5DW, UK; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter EX1 2LU, UK.
Andrew ParrishDepartment of Molecular Genetics, Royal Devon and Exeter NHS Foundation Trust, Exeter EX2 5DW, UK.
Karen StalsDepartment of Molecular Genetics, Royal Devon and Exeter NHS Foundation Trust, Exeter EX2 5DW, UK.
Josue Flores-DaboubDepartment of Pediatric Genetics, University of Utah School of Medicine, Salt Lake City, UT 84108, USA.
Shalini N JhangianiHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
Richard A GibbsDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston TX 77030, USA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
Baylor-Hopkins Center for Mendelian Genomics
Han G BrunnerDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Department of Clinical Genetics, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6202 AZ Maastricht, the Netherlands.
V Reid SuttonDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston TX 77030, USA; Texas Children's Hospital, Houston, TX 77030, USA.
James R LupskiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston TX 77030, USA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA; Texas Children's Hospital, Houston, TX 77030, USA.
Claudia M B CarvalhoDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston TX 77030, USA. Electronic address: cfonseca@bcm.edu.
Baylor College of Medicine · USRadboud University Nijmegen · NLAnkara University · TRErzurum Regional Training and Research Hospital · TRHôpital Nord · FRİstanbul Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi · TRIstanbul University · TRMercy Children's Hospital · USRoyal Devon & Exeter NHS Foundation Trust · GBUniversidade de Brasília · BRBrazilian Biosciences National Laboratory · BRInserm · FRJohns Hopkins University · USNuffield Orthopaedic Centre · GBThe University of Texas MD Anderson Cancer Center · USUniversity of Exeter · GBUniversity of Utah · USWashington University in St. Louis · US

Funding

Baylor-Johns Hopkins Center for Mendelian GeneticsUM1HG006542 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2016 to 2020
$14.5M
PROGRAM IN HUMAN MOLECULAR GENETICST32GM008307 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI SHAULSKY, GAD · 1990 to 2020
$6.6M
NHGRI NIH HHS UM1 HG006542NIGMS NIH HHS T32 GM008307
6 · The paper itself

Abstract

Locus heterogeneity characterizes a variety of skeletal dysplasias often due to interacting or overlapping signaling pathways. Robinow syndrome is a skeletal disorder historically refractory to molecular diagnosis, potentially stemming from substantial genetic heterogeneity. All current known pathogenic variants reside in genes within the noncanonical Wnt signaling pathway including ROR2, WNT5A, and more recently, DVL1 and DVL3. However, ∼70% of autosomal-dominant Robinow syndrome cases remain molecularly unsolved. To investigate this missing heritability, we recruited 21 families with at least one family member clinically diagnosed with Robinow or Robinow-like phenotypes and performed genetic and genomic studies. In total, four families with variants in FZD2 were identified as well as three individuals from two families with biallelic variants in NXN that co-segregate with the phenotype. Importantly, both FZD2 and NXN are relevant protein partners in the WNT5A interactome, supporting their role in skeletal development. In addition to confirming that clustered -1 frameshifting variants in DVL1 and DVL3 are the main contributors to dominant Robinow syndrome, we also found likely pathogenic variants in candidate genes GPC4 and RAC3, both linked to the Wnt signaling pathway. These data support an initial hypothesis that Robinow syndrome results from perturbation of the Wnt/PCP pathway, suggest specific relevant domains of the proteins involved, and reveal key contributors in this signaling cascade during human embryonic development. Contrary to the view that non-allelic genetic heterogeneity hampers gene discovery, this study demonstrates the utility of rare disease genomic studies to parse gene function in human developmental pathways.

Indexed as

Genetic HeterogeneityAdolescentAdultBase SequenceChildChild, PreschoolChromosome SegregationCraniofacial AbnormalitiesDiagnosis, DifferentialDwarfismFemaleGenes, DominantGenetic Association StudiesHumansLimb Deformities, CongenitalMaledual molecular diagnosisFrizzledhuman embryonic developmentskeletal dysplasia

Identifiers

PMID29276006
PMCPMC5777383
OpenAlexW2781103078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.